This article was written by Follow Fredrik Arnold is a retired quality service analyst sharing investment ideas with a primary focus on dividend yields...
This article was written by Follow Manika is a macroeconomist with over 20 years of experience in industries including investment management, stock broking, investment...
This article was written by Follow Leo Nelissen is an analyst focusing on major economic developments related to supply chains, infrastructure, and commodities. He...
As everyone knows, Monster Beverage (NASDAQ:MNST) has been a stock that has given spectacular returns to its shareholders so far for decades. It has...
BiomX logo (BiomX website) BiomX Inc. (NYSE:PHGE) is a clinical-stage biotech company that develops bacteriophage (“phage”) cocktails to treat various diseases utilizing its next-generation...
Back in March, I placed a “Sell” rating on Beyond Meat (NASDAQ:BYND), saying management greatly misread demand for its product. I reiterated my “Sell”...
Investment Thesis In my opinion, Bristol-Myers Squibb (NYSE:BMY) stands at a critical juncture. My forthcoming analysis contends that the company’s valuation and future market...
In my last post, I initiated coverage of Algoma Steel (NASDAQ:ASTL), explaining my reasoning that through Algoma Steel’s current cost model with its Basic...